Home/Filings/4/0001326110-23-000113
4//SEC Filing

Simon Barry J. 4

Accession 0001326110-23-000113

CIK 0001326110other

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 7:39 PM ET

Size

7.2 KB

Accession

0001326110-23-000113

Insider Transaction Report

Form 4
Period: 2023-09-01
Transactions
  • Exercise/Conversion

    Common Stock

    2023-09-01+57,1993,088,655 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-0157,19957,200 total
    Common Stock (57,199 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
  • [F2]Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 57,199 of the RSUs subject to the award vested on September 1, 2023 and 57,200 of the RSUs subject to the award shall vest on January 31, 2024.

Issuer

ImmunityBio, Inc.

CIK 0001326110

Entity typeother

Related Parties

1
  • filerCIK 0001647994

Filing Metadata

Form type
4
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 7:39 PM ET
Size
7.2 KB